MoonLake Immunotherapeutics - Ordinary Shares - Class A

:MLTX 3:47:38 PM EDT

5.71

-0.08 (-1.38%)

Equity Investments, Regulatory, Other Pre-Announcement

Merck Healthcare Reports 8.3% Passive Stake In Moonlake Immunotherapeutics

Published: 08/03/2022 11:31 GMT

MoonLake Immunotherapeutics - Ordinary Shares - Class A (MLTX) - Merck Healthcare Kgaa Reports 8.3% Passive Stake in Moonlake Immunotherapeutics As of August 6 - Sec Filing.
Further Company Coverage: Mltxo ((reuters.
Briefs@thomsonreuters.
Com;)).